- Details
- Hits: 760
- Notice of the Annual General Meeting of Shareholders 2018
- Confirmation paper or Power of Attorney to attend the Annual General Meeting of Shareholders 2018
- Proposed contents and agenda at the Annual General Meeting of Shareholders 2018
- List of documents at the Annual General Meeting of Shareholders 2018
- Meeting agenda, working regulation and voting rule.
- Report of the Board of Directors (BOD) Term III (2014 – 2018).
- Report of the Board of Supervisory (BOS) Term III (2014 – 2018).
- Audited consolidated financial statements 2018.
- Statement regarding the profit distribution 2018 and the profit distribution plan 2019.
- Statement regarding the selection of an independent auditor for 2019 financial statements.
- The resignation letter from the Supervisor position of Ms. Nguyen Phuong Thao
- Statement on the supplements and amendments of DHG Pharma’s business lines
- Statement on changing organizational structure, management and control from the BOS model to the Audit Committee model under the BOD of DHG Pharma
- Reference table on the amendments and supplements of the Charter of DHG Pharma
- Reference table on the amendments and supplements of the Internal Regulation on Corporate Governance of DHG Pharma
- Statement on the quantity and member structure of the BOD Term IV (2019 – 2023)
- Statement on the nomination/candidacy list and curriculum vitae of candidates
- Information related to the candidates for the BOD
- Voting Rule of the BOD Term IV (2019 – 2023) of DHG Pharma
- Election ballot for the BOD member Term IV (2019 – 2023) of DHG Pharma
- Voting ballot at the Annual General Meeting of Shareholders 2018
- Draft Resolution of the Annual General Meeting of Shareholders 2018
- Details
- Hits: 830
- Notice regarding the candidacy and nomination of the Board of Directors’ members of DHG Pharma Term IV (2019 – 2023)
- Candidacy/nomination application form to join the Board of Directors
- Curriculum vitae of nominees for the Board of Directors
- Declaration for the purpose of verifying independence and commitment of an independent BOD member